Weiss Multi-Strategy Advisers’s Edwards Lifesciences EW Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-41,345	Closed	-$2.86M	–	587
2023 Q3	$2.86M	Sell	41,345 -93,364	-69%	-$7.5M	0.07%	327
2023 Q2	$12.7M	Sell	134,709 -40,035	-23%	-$3.48M	0.26%	104
2023 Q1	$14.5M	Buy	174,744 +104,314	+148%	+$8.2M	0.34%	86
2022 Q4	$5.25M	Sell	70,430 -31,096	-31%	-$2.4M	0.15%	213
2022 Q3	$8.39M	Sell	101,526 -10,190	-9%	-$981K	0.22%	150
2022 Q2	$10.6M	Buy	111,716 +26,616	+31%	+$2.76M	0.32%	94
2022 Q1	$10M	Sell	85,100 -587	-0.7%	-$65.9K	0.23%	151
2021 Q4	$11.1M	Buy	85,687 +434	+0.5%	+$50.6K	0.25%	116
2021 Q3	$9.65M	Buy	85,253 +1,086	+1%	+$124K	0.21%	155
2021 Q2	$8.72M	Buy	84,167 +3,014	+4%	+$284K	0.19%	166
2021 Q1	$6.79M	Buy	81,153 +1,114	+1%	+$94.2K	0.15%	205
2020 Q4	$7.3M	Buy	80,039 +39	+0%	+$3.23K	0.14%	201
2020 Q3	$6.39M	Buy	80,000 +4,633	+6%	+$361K	0.17%	181
2020 Q2	$5.21M	Buy	75,367 +5,971	+9%	+$424K	0.15%	205
2020 Q1	$4.36M	Buy	69,396 +34,896	+101%	+$2.52M	0.17%	173
2019 Q4	$2.68M	Buy	34,500 +4,500	+15%	+$351K	0.04%	396
2019 Q3	$2.2M	Hold	30,000	–	–	0.04%	368
2019 Q2	$1.85M	Sell	30,000 -15,000	-33%	-$907K	0.05%	315
2019 Q1	$2.87M	Sell	45,000 -15,000	-25%	-$856K	0.07%	286
2018 Q4	$3.06M	Buy	60,000 +11,856	+25%	+$600K	0.13%	184
2018 Q3	$2.79M	Sell	48,144 -7,185	-13%	-$351K	0.07%	287
2018 Q2	$2.69M	Sell	55,329 -4,671	-8%	-$218K	0.06%	302
2018 Q1	$2.79M	Sell	60,000 -45,000	-43%	-$1.95M	0.09%	271
2017 Q4	$3.94M	Sell	105,000 -12,000	-10%	-$440K	0.1%	227
2017 Q3	$4.26M	Sell	117,000 -17,064	-13%	-$651K	0.16%	189
2017 Q2	$5.28M	Sell	134,064 -8,775	-6%	-$320K	0.22%	145
2017 Q1	$4.48M	Buy	142,839 +49,506	+53%	+$1.55M	0.18%	157
2016 Q4	$2.92M	Buy	93,333 +33,105	+55%	+$1.07M	0.14%	150
2016 Q3	$2.42M	Sell	60,228 -3,582	-6%	-$135K	0.15%	191
2016 Q2	$2.12M	Sell	63,810 -38,649	-38%	-$1.32M	0.16%	180
2016 Q1	$3.01M	Sell	102,459 -105	-0.1%	-$2.9K	0.13%	212
2015 Q4	$2.7M	Sell	102,564 -10,266	-9%	-$267K	0.19%	137
2015 Q3	$2.67M	Buy	112,830 +2,874	+3%	+$69.4K	0.12%	151
2015 Q2	$2.61M	Buy	109,956 +32,556	+42%	+$735K	0.1%	211
2015 Q1	$1.84M	Buy	77,400 +17,400	+29%	+$390K	0.08%	252
2014 Q4	$1.27M	Sell	60,000 -18,000	-23%	-$362K	0.04%	255
2014 Q3	$1.33M	Sell	78,000 -15,360	-16%	-$242K	0.03%	347
2014 Q2	$1.34M	Sell	93,360 -63,720	-41%	-$864K	0.03%	382
2014 Q1	$1.94M	Sell	157,080 -24,714	-14%	-$285K	0.04%	358
2013 Q4	$1.99M	Buy	181,794 +38,154	+27%	+$430K	0.04%	336
2013 Q3	$1.67M	Sell	143,640 -36,360	-20%	-$425K	0.04%	362
2013 Q2	$2.02M	Buy	+180,000	New	+$2.13M	0.06%	321

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Weiss Multi-Strategy Advisers's EW Position: Q4 2023 in Review

Weiss Multi-Strategy Advisers sold out of Edwards Lifesciences (EW) in Q4 2023, closing a stake of 41,345 shares — an estimated $2.86M sold.

Weiss Multi-Strategy Advisers first reported a position in EW in Q2 2013 and held it in 42 quarters. The position peaked at $14.5M in Q1 2023. 1,244 funds tracked by Wall St. Rank hold EW as of Q4 2023.

Weiss Multi-Strategy Advisers reported no remaining Edwards Lifesciences position as of Q4 2023 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 41,345 Edwards Lifesciences shares in Q4 2023, an estimated $2.86M.
Weiss Multi-Strategy Advisers first reported a position in Edwards Lifesciences in Q2 2013 and held it in 42 quarters.
Weiss Multi-Strategy Advisers's Edwards Lifesciences position peaked at $14.5M in Q1 2023.
1,244 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.